Business Standard

Australia approves Remdesivir for Covid-19 treatment as cases rise

The approval comes as Australia is seeing a sharp increase in coronavirus infections in the state of Victoria

remdesivir, coronavirus
Premium

After Gilead’s repurposed drug came into the limelight, the US firm signed licence agreements with Indian manufacturers around mid-May to make and sell the drug in India and other countries.

AP | PTI Canberra
Australia's Therapeutic Goods Administration has given provisional approval to the drug remdesivir, an experimental medicine that has shown promise in the recovery time of the most seriously ill Covid-19 patients.

The approval comes as Australia is seeing a sharp increase in coronavirus infections in the state of Victoria, which reported a record 288 new confirmed cases Friday.

Authorities say remdesivir will be available only to patients who are severely ill, require oxygen or high-level support to breathe, and are in hospital care.


It is

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in